Cytomegalovirus Infection of the Colon Presenting as a Mass-Like Lesion by Tan, Christopher B. et al.
 
Case Rep Gastroenterol 2012;6:266–272 
DOI: 10.1159/000338842 
Published online: 
May 10, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
This is an Open Access article licensed under the terms of the Creative Commons 
Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable 
to the online version of the article only. Distribution for non-commercial purposes only.   
 
                      Christopher B. Tan, MD    Department of Medicine, Nassau University Medical Center 
2201 Hempstead Turnpike, East Meadow, NY 11554 (USA) 
E-Mail ctan @ numc.edu 
 
266 
   
Cytomegalovirus Infection 
of the Colon Presenting as 
a Mass-Like Lesion 
Christopher B. Tan
a    Magdalene Vardaros
b    
Apsara Prasad
b    Sadat Rashid
b    Keith Dahl
b    
Duane Moise
b    Wondwoosen Gebre
c    Kaleem Rizvon
b    
Paul Mustacchia
b  
Departments of 
aMedicine, 
bGastroenterology and 
cPathology, Nassau 
University Medical Center, East Meadow, N.Y., USA 
 
 
Key Words 
Cytomegalovirus infection · Colon · Mass-like lesion 
 
 
Abstract 
Cytomegalovirus (CMV) is responsible for the most common opportunistic infections in 
patients with acquired immunodeficiency syndrome (AIDS). The colon is a common site for 
these infections in patients positive for human immunodeficiency virus. CMV rarely presents 
as an intraluminal inflammatory mass in the colon. Here we report the case of a CMV 
infection presenting as a mass-like lesion in an AIDS patient. The clinical diagnosis of CMV 
infection is largely based on the characteristic endoscopic appearance. Endoscopic 
procedures are encouraged early in the course of CMV infection in immunocompromised 
patients. CMV pseudotumors along with malignancy should be part of the endoscopic 
evaluation in patients with AIDS. 
 
Introduction 
Cytomegalovirus (CMV) is an enveloped, double-stranded, Herpesviridae DNA virus 
that commonly infects immunocompetent and immunocompromised individuals [1, 2]. 
It is transmitted from person to person by saliva, respiratory droplet, breast milk, blood 
transfusion, sexual contact and organ transplantation [1, 3]. Primary CMV infection 
occurs at any age. CMV establishes latent infection in the myeloid precursor cells of the 
bone marrow after the initial inciting event. In the normal host, it remains suppressed 
and under control by the strong virus-specific CD4+ T cell and CD8+ T cell responses. 
Reactivation of latent infection occurs in patients with impaired T cell function as a  
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result of transplantation, acquired immunodeficiency syndrome (AIDS), or 
immunosuppressive treatment [1]. CMV infection induces a transient viremia by which 
it reaches all parts of the body, subsequently creating a wide spectrum of diseases, 
including retinitis, colitis, myocarditis, pneumonia, infectious mononucleosis, 
congenital disease and acute renal failure in renal transplant patients [1, 3]. Although 
this agent rarely causes morbidity in normal immunologic hosts, its virulence is quite 
different in patients with AIDS [2]. 
The prevalence of gastrointestinal involvement with CMV in AIDS ranges from 30 
to 40% [4, 5]. It has the ability to affect the entire gastrointestinal tract from the 
esophagus to the rectum and may include the pancreas, liver and gallbladder [4]. 
Clinical presentation of CMV infection in the gastrointestinal tract depends on the 
extent and the location of the pathologic lesions. Gastrointestinal CMV most commonly 
manifests as erosive colitis and esophagogastritis with chronic diarrhea, fever, 
abdominal pain, weight loss, melena and hematochezia [6, 7]. Perforation, hemorrhage 
and toxic megacolon have also been reported. CMV-induced gastrointestinal 
pseudotumors in AIDS usually present with abdominal pain in 71% of cases and with 
fever, change of bowel habits, weight loss and palpable mass in the remaining. About a 
third of CMV pseudotumors presented as an obstructing mass in a recent case series 
[7]. 
Most gastrointestinal CMV infections manifest as ulcerative lesions, but 
non-ulcerative lesions have also been reported [8]. Kaposi’s sarcoma and 
non-Hodgkin’s lymphoma are the most common intraluminal lesions encountered in 
AIDS. However, a less common cause of mass-like lesion in AIDS can be induced by CMV 
[9]. Here we present the unique case of an intraluminal colonic mass caused by CMV 
infection in an AIDS patient. 
Case Report 
A 67-year-old male with a past medical history of prostate carcinoma, osteoporosis, esophageal 
candidiasis and recently diagnosed AIDS was referred to our emergency department for dizziness and 
syncope. He had experienced persistent dizziness and an episode of syncope a day prior to admission 
associated with easy fatigability but denied any abdominal pain, blood per rectum, diarrhea, 
unintentional weight loss and/or anorexia. Vital signs at admission showed a blood pressure of 
92/63 mm Hg, a pulse of 104/min, a respiratory rate of 16/min and a temperature of 98.1°F. Physical 
examination was remarkable for pallor, oral thrush and a 2/6 systolic murmur. Digital rectal 
examination did not reveal any mass lesions or gross blood. Laboratory results were significant for 
anemia with a hemoglobin of 5.2 g/dl and a hematocrit of 15.2%. Stool occult blood was positive for 
heme-reducing substances. His most recent plasma values were a human immunodeficiency virus 
(HIV) RNA level of 42,219 copies/ml and CD4 count of 24/mm3. He was not on highly active 
antiretroviral therapy (HAART) at that time. 
The patient responded to fluid resuscitation and was monitored in the medical intensive care 
unit. He was scheduled for esophagogastroduodenoscopy (EGD) and colonoscopy to investigate 
the source of bleeding. Two units of packed red blood cells were transfused prior to the procedure. 
EGD showed healing esophageal erosions, gastric erosions and erythematous antrum. Colonoscopy 
revealed an ulcerating mass at the ileocecal valve (fig. 1). Multiple biopsies were taken and sent for 
histopathologic examination. Due to a high suspicion of a possible neoplastic process, a computed 
axial tomography scan of the abdomen and pelvis with contrast was done. It revealed a 
3.8 × 4.5 × 11 cm mass involving the cecum and ascending colon, with marked eccentric wall 
thickening and peripheral enhancement (fig. 2). At least five discrete hypodense liver lesions 
suspicious for metastases were also noted. Surgical pathologic results of the mass came back as  
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fragments of granulation tissue with inflammatory changes highly suggestive of CMV infection (fig. 3). 
The characteristic basophilic inclusion bodies (‘owl’s eye’) were demonstrated within the granulation 
tissue on histologic examination (fig. 4). Special staining for acid-fast bacilli and fungi was negative. 
The patient was started on HAART treatment from which he developed an immune reconstitution 
inflammatory syndrome against the CMV virus with a subsequent increase of the CD4 count to 
284/mm3 and a reduction of the viral load to <48 copies/ml. A repeat CT scan and follow-up 
colonoscopy weeks later did not reveal any colonic mass (fig. 5). 
Discussion 
Intraluminal mass lesions in AIDS are usually related to neoplastic and infectious 
processes. Kaposi’s sarcoma accounts for 60% of malignancies, non-Hodgkin’s 
lymphoma being the next most common etiology (35%). Infections with mycobacteria 
or fungi have also been seen to cause mass-like lesions in the gastrointestinal tract on 
very rare occasions [4, 6]. CMV-associated mass lesion in AIDS is an uncommon entity. 
In a review done by Kelesidis et al. in 2010 [7], there were only 15 cases of CMV 
pseudotumors published in the English literature since 1980 [9]. They have been 
increasingly observed though over the past decade during the advent of HAART 
therapy as survival of these patients has improved. CMV-associated mass lesions have 
been observed throughout the gastrointestinal tract but are most commonly seen in the 
right colon and the ileocecal valve, similar to our case [4]. 
The exact pathophysiology of CMV pseudotumors is not clearly understood [10]. 
The virus has a particular affinity for the gastrointestinal tract, especially the ileum 
and the right colon [11]. It has been postulated that this affinity is associated with its 
strong predilection to vascular endothelial cells causing platelet thrombi formation 
and vascular endothelial thickening with subsequent stromal reaction in the lamina 
propria, thereby resulting in a mass-like lesion often mistaken as a neoplastic process 
[4, 10]. It is important to note that the predominant cells involved in CMV inclusions 
are stromal and epithelial cells, whereas in CMV-induced ulceration, the predominant 
cells are endothelial in origin [7]. 
The diagnosis of gastrointestinal CMV infection is highly dependent on endoscopic 
findings. In a study by Klatt and Shibata [8], premortem diagnosis of CMV infection in 
AIDS appears to be greatly dependent on endoscopic sampling of the lungs and the 
gastrointestinal tract. The endoscopic appearance of CMV infection ranges from focal or 
diffuse mucosal erythema to extensive, deep, friable ulcerations with non-purulent, 
clearly defined borders [6]. It is recognized in detail as a well-circumscribed ulceration 
with persistent inflammation and overlying fibrotic changes [12, 13]. 
The pathologic specimen from tissue biopsy of CMV-infected cells involves a central 
density of eosinophilic inclusion with a surrounding halo, the characteristic ‘owl’s eye’ 
intranuclear inclusion bodies [8, 13, 14]. Although herpes and adenovirus infection may 
also produce similar inclusion bodies, the cells are not as large and do not produce the 
characteristic cytoplasmic basophilic bodies seen in CMV. If the pathologic diagnosis is 
doubtful, an immunohistochemical stain using CMV monoclonal antibodies can provide 
adequate differentiation [8]. Together with biopsy, immuohistochemical staining is 
considered the gold standard in the diagnosis of gastrointestinal CMV [7, 15].  
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Although viral serologies such as a high CMV IgM or rising CMV IgG antibodies are 
useful diagnostic tests for immunocompetent patients, they are not recommended in 
immunocompromised patients due to lack of reliability and correlation with the organs 
involved. Moreover, 90% of AIDS patients are exposed to CMV infection and have had a 
positive antibody in the past, making serologic testing unhelpful. Detection of viral 
nucleic acid by polymerase chain reaction (PCR) has also been widely used to 
demonstrate the presence of CMV. It has fallen out of favor since CMV infection is 
capable of lifelong latency, and a positive PCR would not always suggest CMV 
pathogenicity. The same is true for CMV cultures in which the organism can be isolated 
from human embryonic fibroblast but does not imply active CMV disease [14]. 
Cellular immunity plays a central role in the control of CMV in healthy and 
immunocompromised individuals. Several studies have shown that immune 
reconstitution of specific T cell responses to a number of pathogens, including CMV, can 
occur following a HAART regimen [16–19]. In a study by Deayton et al. [16] on HIV 
patients, CMV DNA levels in the blood rapidly declined after the initiation of HAART. 
The group further concluded that HAART effectively inhibits CMV replication to as 
much as 85%, with a median response rate of 61%. This response serves as an effective 
antiviral activity against CMV infection. Another study by Weinberg et al. [18] on 
reconstitution of CMV in HIV showed similar results. Our patient had the same immune 
reconstitution against the CMV virus after initiation of HAART, as evidenced by the 
disappearance of the mass in CT and colonoscopy despite no specific treatment for 
CMV. 
Pseudotumors related to CMV must be included in the differential diagnosis of AIDS 
patients presenting with gastrointestinal symptoms along with Kaposi’s sarcoma and 
non-Hodgkin’s lymphoma. Endoscopic procedures with multiple biopsies along with 
immunohistochemical staining remain the cornerstone for diagnosis of gastrointestinal 
CMV. Furthermore, one should not stop after the identification of a single pathogen, 
since multiple pathogens can coexist in an immunocompromised host [20]. Physicians 
must hold a high suspicion for CMV pseudotumors since medical treatments have 
proven to be highly effective. Moreover, HIV patients with CMV masses have a grim 
prognosis, and a poorer outcome if left untreated [7]. 
Disclosure Statement 
The authors declare that they have no competing interests. 
 
 
 
 
  
Case Rep Gastroenterol 2012;6:266–272 
DOI: 10.1159/000338842 
Published online: 
May 10, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
 
270 
 
Fig. 1. Colonoscopy showing an ulcerating mass at the ileocecal valve. 
 
 
 
Fig. 2. Computed axial tomography of the abdomen and pelvis showing a large cecal mass measuring 
3.8 × 4.5 × 11 cm (arrow). 
 
 
 
Fig. 3. A Hematoxylin and eosin stain of the mass-like lesion (20× magnification). Note the 
normal-appearing colonic mucosa with preserved glandular tissues. B The mass-like lesion with 
active areas of inflammation and complete distortion of glandular tissues. 
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Fig. 4. Hematoxylin and eosin stain of the same mass (60× magnification). Note the basophilic 
inclusion bodies ‘owl’s eye’ appearance, characteristic of CMV infection (arrows). 
 
 
 
Fig. 5. Follow-up colonoscopy. Note the complete resolution of the mass at the ileocecal junction. 
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